about
Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinomaRAD51 protein expression is increased in canine mammary carcinomasGene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failureRAD51AP2, a novel vertebrate- and meiotic-specific protein, shares a conserved RAD51-interacting C-terminal domain with RAD51AP1/PIR51.Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer riskAdenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells.Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristicsVariation in the RAD51 gene and familial breast cancer.Tumor-associated mutations in a conserved structural motif alter physical and biochemical properties of human RAD51 recombinase.Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.RAD51 variant proteins from human lung and kidney tumors exhibit DNA strand exchange defectsPolymorphisms in RAD51 and their relation with breast cancer in Saudi females.Polymorphisms in DNA Repair Gene XRCC3 and Susceptibility to Breast Cancer in Saudi Females.Use of the Rad51 promoter for targeted anti-cancer therapyHistone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines.DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.Polymorphisms of the homologous recombination gene RAD51 in keratoconus and Fuchs endothelial corneal dystrophyRelationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies.Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.Environmental-mediated drug resistance: a target for multiple myeloma therapy.DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis.MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks.MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination.(-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer.Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.Defects in recombination activity caused by somatic and germline mutations in the multimerization/BRCA2 binding region of human RAD51 protein.Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis.Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair.High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.A primitive neuroectodermal tumor in an adult: Case report of a unique location and MRI characteristics.Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis.Role of geminin: from normal control of DNA replication to cancer formation and progression?Assessment of DNA Binding to Human Rad51 Protein by using Quartz Crystal Microbalance and Atomic Force Microscopy: Effects of ADP and BRC4-28 Peptide Inhibitor
P2860
Q28242915-39D0919E-CD75-4E32-82AB-3861BC990CF8Q28270630-9B8C5D31-07FE-4601-A692-8F9161141E28Q30578079-AD50FAF8-7B61-4871-B23C-57229DB8D011Q30824047-778CE5A0-83A7-442D-9E6E-5E048EF8D95AQ33943829-DD774678-C226-47DE-91F8-8732586F3E7BQ34103307-EF98C6ED-E236-45B0-93F5-F2E5C757882EQ34114810-957DFE36-C259-4F0F-82DB-4FCA1763DA29Q34267466-27C61D7F-1EF3-433A-8A38-27A790100BD3Q35012867-04DB736B-4083-4268-8B3C-0E547CF3AD9EQ35097983-A735E156-0B0F-49C1-A2B4-DD7E5F90B019Q35750271-4949C3F0-365F-4853-BE83-2B05C553F31FQ35988515-6B699F7E-524C-4585-A00D-3DEB0EBD3F2BQ36010976-D316CC0D-BC66-4B0D-8665-5DB8E06C2EBCQ36473585-FD218D66-D3C4-45BC-A295-9CFA1858C338Q36530935-EAA52B9F-6137-40B6-9A7F-B9EF94180A9AQ37081622-087046AD-CBE0-4D97-8F76-D83C72CA9A37Q37097022-CC538CA3-2CCC-4F3F-A2F9-2D46461301A7Q37229934-DE0763FE-932F-46BE-952C-031550BEC60AQ37259859-04085B99-3870-439A-9497-145571E61773Q37521105-9C156733-B1B2-4A97-BC4C-14C9951C31F3Q37640950-82BCA785-A986-4C34-9B67-2D6383E8FE33Q37810085-1C5D3BD0-BB55-4ECF-996B-54319CC8D41DQ38106985-AB08409D-B569-40EA-B668-1EAAFDAEC05BQ38129804-1DAD7D5B-6605-4ABC-B9F3-ECE9DD24156DQ39576714-F72B70B2-4396-4D6B-8722-AE19A6708577Q40547188-E3990902-F56E-43A8-8A20-1E32EBFEDA2EQ41611232-AA9455A7-DF48-4495-9F0D-01B803533671Q42321598-A53A6796-89CA-42AC-BACA-715AFB8601F1Q43749889-AB7C0BDA-12C6-49CB-B251-9E22B51DBE9FQ46058177-350880FC-3365-4FAE-B1B8-D2646211F6C2Q47445010-4ABF459B-746A-49EB-881F-5BDC5C4EE266Q47721960-C3EAA0FE-1ED1-4120-BDA3-196CC3BBAC4FQ47912248-C998B785-16C3-4339-81A4-B76265460AD8Q49153890-FF5D4041-8ACC-4C5C-AED4-B3E5DC366838Q50003151-ADCBF331-A2E2-40D0-9D5F-D05F793CE97CQ50909910-8A377C22-2CD2-4B2F-B8C6-B08A996A470DQ52347275-12822479-7524-4A23-B72D-86913A10B26DQ52571383-D3D58BA9-474D-49C2-8A21-187DB38DE948Q53626522-61CA81C9-D004-4449-824A-27C717DD74E6Q56992568-44871ACA-437A-40F9-B15B-811FEAFFB210
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
RAD51, genomic stability, and tumorigenesis.
@ast
RAD51, genomic stability, and tumorigenesis.
@en
type
label
RAD51, genomic stability, and tumorigenesis.
@ast
RAD51, genomic stability, and tumorigenesis.
@en
prefLabel
RAD51, genomic stability, and tumorigenesis.
@ast
RAD51, genomic stability, and tumorigenesis.
@en
P1433
P1476
RAD51, genomic stability, and tumorigenesis.
@en
P2093
Christine Richardson
P304
P356
10.1016/J.CANLET.2004.08.009
P407
P577
2005-02-01T00:00:00Z